{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-002295","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2025-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.617019+00:00","generated_at":"2026-05-24T01:10:43.645681+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NeOnc raises $1.6M placement; partners CBCC for India GBM trial","bullets":["Private placement gross proceeds ~$1.6M at $16/share for working capital.","Strategic partnership with CBCC Global Research to enroll patients at 30 FDA-compliant sites in India.","Partnership targets Phase 2a NEO100-01 GBM trial; enrollment completion expected this year, readout 6-8 months after.","Financing is unregistered under Rule 506(b) to accredited investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-002295","json":"https://secwatch.observer/filing/0001829126-25-002295.json","markdown":"https://secwatch.observer/filing/0001829126-25-002295.md","text":"https://secwatch.observer/filing/0001829126-25-002295.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/0001829126-25-002295-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625002295/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:10:43.645681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}